Lu LY et al. |
Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. |
2017 |
J. Orthop. Res. |
pmid:28248001
|
Ozaki Y et al. |
Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. |
2017 |
PLoS ONE |
pmid:28937990
|
Tschiderer L et al. |
Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. |
2017 |
PLoS ONE |
pmid:28837646
|
Åšliwicka E et al. |
Serum irisin and myostatin levels after 2 weeks of high-altitude climbing. |
2017 |
PLoS ONE |
pmid:28732027
|
Bergdolt S et al. |
Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. |
2017 |
PLoS ONE |
pmid:28614388
|
Spirlandeli AL et al. |
Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment. |
2017 |
Clinics (Sao Paulo) |
pmid:28492723
|
Liu J et al. |
MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. |
2017 |
PLoS ONE |
pmid:28319142
|
Songia P et al. |
Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. |
2017 |
Oxid Med Cell Longev |
pmid:28261377
|
Jia J et al. |
Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. |
2017 |
Mol Med Rep |
pmid:28260003
|
Yu M et al. |
Chemotherapy effectively suppresses interleukin-20, receptor activator of nuclear factor kappa-B ligand, and osteoprotegerin levels in patients with lung adenocarcinoma and bone metastasis. |
2016 Apr-Jun |
J Cancer Res Ther |
pmid:27461682
|
Kose O et al. |
Influences of Fucoxanthin on Alveolar Bone Resorption in Induced Periodontitis in Rat Molars. |
2016 |
Mar Drugs |
pmid:27043583
|
Shah AP et al. |
Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. |
2016 |
PLoS ONE |
pmid:27019421
|
Dela Cruz A et al. |
Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. |
2016 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:27006198
|
Yuan SY et al. |
Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. |
2016 |
Chin J Nat Med |
pmid:27114313
|
Davaine JM et al. |
Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. |
2016 |
Eur J Vasc Endovasc Surg |
pmid:26652270
|
Li J et al. |
Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro. |
2016 |
Mol Med Rep |
pmid:26647856
|
O'Sullivan S et al. |
Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. |
2016 |
PLoS ONE |
pmid:27737004
|
Li M et al. |
Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis. |
2016 |
J. Biol. Chem. |
pmid:27697839
|
Shirakawa J and Kulkarni RN |
Novel factors modulating human β-cell proliferation. |
2016 |
Diabetes Obes Metab |
pmid:27615134
|
Xing R et al. |
Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. |
2016 |
Int. J. Mol. Med. |
pmid:27599586
|